Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Open-label Randomised Phase III Trial of the Efficacy of Sodium Thiosulphate in Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy for Standard Risk Hepatoblastoma

NCT00652132 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT00652132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00652132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Open-label Randomised Phase III Trial of the Efficacy of Sodium Thiosulphate in Reducing Ototoxicity in Patients Receiving Cisplatin Chemotherapy for Standard Risk Hepatoblastoma
Lead sponsor
University of Birmingham
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2007
Completion date
February 28, 2018
Enrollment
116 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, ototoxicity